Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 27 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 8961993

    Method of treating retinitis pigmentosa

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  2. US 8956601

    Therapeutic uses of mastic gum fractions

    REGENERA PHARMA LTD. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted
  3. US 8957033

    Inhibitor of sodium-dependent glucose transport protein and preparation method therefor and use thereof

    Beijing Prelude Pharm. SCI. & Tech. Co., Ltd. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted
  4. US 8946167

    Pharmaceutical compositions containing plasma protein

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted
  5. US 8946300

    Use of rasagilline for the treatment of restless legs syndrome

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted
  6. US 8940685

    Method for preparing active peptides from corn germ proteins

    CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD. · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted
  7. US 8937082

    Nilotinib salts and crystalline forms thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted
  8. US 8937053

    Process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted
  9. US 8920373

    Reduced volume formulation of glatiramer acetate and methods of administration

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  10. US 8912172

    Skin external preparation containing triterpenic acid

    KURARAY CO., LTD. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted
  11. US 8900574

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  12. US 8889627

    Treatment of multiple sclerosis with combination of laquinimod and fingolimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  13. US 8889213

    Processes for coating a carrier with microparticles

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  14. US 8889661

    Treatment of lupus nephritis using laquinimod

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  15. US 8883161

    Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant

    PROTEIN DESIGN LAB, LTD. · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  16. US 8871907

    Glycosylated immunoglobulin and immunoadhesin comprising the same

    KOREA PRIME PHARM CO., LTD. · Granted Oct 28, 2014 · Expires Oct 23, 2034

    granted
  17. US 8865722

    Wet formulations of aripiprazole

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  18. US 8858925

    Pegylated fibrinogen precursor molecule

    REGENTIS BIOMATERIALS LTD. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted
  19. US 8846020

    Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof

    REGENTIS BIOMATERIALS LTD. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  20. US 8846635

    Method for inducing hepatocyte proliferation and uses thereof

    CAN-FITE BIOPHARMA LTD. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  21. US 8828722

    Isolated populations of renal stem cells and methods of isolating and using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  22. US 8828725

    Culture medium

    HON HAI PRECISION INDUSTRY CO., LTD. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  23. US 8815511

    Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  24. US 8809310

    Use of rasagiline for the treatment of multiple system atrophy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted